Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules
Authors not listed
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · 2021
Abstract
A clinical study to evaluate the long-term safety of Sodium Oligomannate Capsules (GV-971)
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2021). A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules. <em>Green Valley (Shanghai) Pharmaceuticals Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT05058040
Vancouver
Anonymous. A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules. Green Valley (Shanghai) Pharmaceuticals Co., Ltd.. 2021.
BibTeX
@misc{anon2021AClini,
title = {A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules},
author = {Anonymous},
journal = {Green Valley (Shanghai) Pharmaceuticals Co., Ltd.},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Meribank Biotech Co., Ltd. 2024
Open access · US-GOV
A Two-part, Phase I/II, Randomized, Single-blind Study to Evaluate the Efficacy and Safety of UMC119-06-05 in Older Adults With Pre-frailty & Frailty
Abbott 2009
Open access · US-GOV
A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study
SIPO Biotechnology Co. Ltd. 2027
Open access · US-GOV
A Randomized, Double-blind, Placebo-controlled Exploratory Clinical Study to Evaluate the Safety and Tolerability of SPOT-mRNA01 Injection in Healthy Adult Subjects.
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2020
Open access · US-GOV
A Phase 3, Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Sodium Oligomannate (GV-971) in Treatment of Mild to Moderate Alzheimer's Disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory)
Gyroscope Therapeutics Limited 2022
Open access · US-GOV
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Novartis Pharmaceuticals 2014
Open access · US-GOV